News | June 04, 2009

Leadless Pacing is Feasible, Says New Study

June 4, 2009 – New research proves the feasibility of leadless pacing in heart failure patients with ultrasound-mediated stimulation energy, which was published in the June edition of the HeartRhythm Journal, the journal of the Heart Rhythm Society (HRS).

The study sought to apply ultrasound-mediated leadless pacing technology in heart failure patients and to evaluate the effects of respiration and body posture on the acoustic window. HRS said the study is the first of its kind to demonstrate successful leadless pacing in human subjects with advanced heart failure.

Conducted by a team of researchers at the Queen Mary Hospital in Hong Kong in 2006, 10 patients were identified who underwent diagnostic testing with coronary angiography and left ventriculography. Patients who were age 18 or older, had an ejection fraction of less than or equal to 35 percent and were in New York Heart Association (NYHA) functional class III or IV were eligible to participate. An electrophysiology catheter incorporating a receiver-electrode to deliver ultrasound-mediated pacing was positioned in the left ventricle to determine the thresholds. The acoustic windows on the chest wall were determined based on the effects of respiration while the patients were lying on their back, tilted 30 degrees leftward, rightward and upward.

“It was our objective to conduct a study that would demonstrate the feasibility of leadless pacing in patients with advanced heart failure,” said lead author Dr. Kathy L. Lee, MBBS, from the department of medicine at the Queen Mary Hospital in Hong Kong. “We believe our study will generate further interest in leadless pacing and encourage future technological advancements in this area.”

The results of the study found ultrasound-mediated pacing to be successful in all 10 patients who participated, showing a 100 percent success rate. The acoustic window size was adequate for ultrasound transmission from the chest surface to a receiver electrode in the left ventricle, regardless of patient position or respiratory phase. Thus, the ability to perform leadless left ventricular pacing in heart failure patients using the novel technology under development proves to be feasible.

Leadless pacing is a potential breakthrough in pacing technology that provides the advantage to avoid all complications related to the insertion and existence of a pacing lead, such as infections and lead dysfunction, which can lead to severe cardiac problems or death.

For more information: www.heartrhythmjournal.com

Related Content

Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT)| August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
Ohio State Researchers Prove Human Heart's 'Battery' Has Multiple Backups
News | EP Lab| July 27, 2017
July 27, 2017 — There is good news when it comes to the heart’s sinoatrial node (SAN), the body’s natural...
Medtronic Reactive ATP Therapy Slows Progression of Atrial Fibrillation in Real-World Population
News | Atrial Fibrillation| July 03, 2017
Medtronic recently announced that its Reactive ATP therapy slows the progression of atrial fibrillation (AF) in...
Biosense webster multielectrode balloon RF ablation catheter

The Biosense Webster multi-electrode balloon RF ablation catheter. Each electrode can have varied power settings to avoid damage to underlying tissues like the esophagus. 

Feature | EP Lab| June 22, 2017 | Dave Fornell
Electrophysiology (EP) technology has been advancing rapidly the past few years with new ablation tools to improve...
Pacemakers and Other Cardiac Devices Can Help Solve Forensic Cases
News | Pacemakers| June 20, 2017
Pacemakers and other cardiac devices can help solve forensic cases, according to a study presented at the European...
BioTrace Medical's Tempo Lead Shows Stability and Safety in Real-World Performance
News | Leads Implantable Devices| June 20, 2017
BioTrace Medical Inc. announced that the company’s Tempo Temporary Pacing Lead was featured in an oral presentation and...
Sponsored Content | Videos | EP Lab| May 26, 2017
DAIC Editor Dave Fornell takes a tour of some of the most innovative new electrophysiology (EP) technology at the 201
Sponsored Content | Videos | Leads Implantable Devices| May 25, 2017
Bruce Wilkoff, M.D., director of cardiac pacing and tachyarrhythmia devices at Cleveland Clinic, discusses advancemen
Sponsored Content | Videos | Pacemakers| May 23, 2017
Vivek Reddy, M.D., director of cardiac arrhythmia services and professor of medicine, cardiology, Mount Sinai Hospita
Sponsored Content | Videos | EP Lab| May 17, 2017
This video, provided by Spectranetics, demonstrates how to deploy the Bridge Occlusion Balloon used to seal accidenta
Overlay Init